Spain - Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale

Since 2014, Spain Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale rose 7.5% year on year. With €176,754,726.66 in 2019, the country was number 6 among other countries in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale. Spain is overtaken by France, which was number 5 at €642,378,032.96 and is followed by Hungary with €123,176,988.66. Denmark topped the ranking with €3,801,340,964.3 in 2019, a decrease of 2.9% compared to 2018. Belgium, Italy and Germany respectively ranked number 2, 3 and 4 in this ranking. Italy witnessed the best average annual growth at +51.7% per year, while Netherlands was the worst growing country at -13.4% per year.

Loading...

Date Euros
2019 176,754,726.66
2018 176,338,057.00
2017 166,322,624.00
2016 153,995,200.00
2015 128,581,765.00
Download all data from 1995 to 2019

How does Spain rank in Sold Production of Medicaments Containing Corticosteroid Hormones, Their Derivatives and Structural Analogues, Put Up in Measured Doses or for Retail Sale?

# 16 Countries Euros Last YoY 5‑years CAGR
1 #1
Denmark
3,801,340,964.30 2019 -2.9 % +26.5 % View data
2 #2
Belgium
1,624,727,500.00 2018 +46.2 % NA View data
5 #5
France
642,378,032.96 2019 +2.7 % -2.6 % View data
6 #6
Spain
176,754,726.66 2019 +0.2 % +7.5 % View data
7 #7
Hungary
123,176,988.66 2019 +7.5 % +10.1 % View data
Compare all 16 countries

Go Top